Bergamo, Italy : 12 - 14 February 2020
Take a look back at the 2018 edition...
150 participants from 30 countries gathered in Amsterdam for A Matter of Life or Death: From Basic Cell Death Mechanisms to Novel Cancer Treatments (01 - 03 February 2018), held in the picturesque former hidden church, De Rode Hoed.
150 participants | 30 countries represented | 75 posters presented | 6 proffered papers
100% of participants would recommend the conference to others
100% satisfaction rating for the quality of the scientific content at the conference
“I found the meeting to be one of the best I have experienced in terms of up front and on-site organization, information and friendliness. It had a great balance of experienced and younger researchers. The aura was informal and very good for interactions at all levels.”
“The conference was excellent. I felt lucky to be there with so many people who are prospering in their fields.”
“It was amazing how people interacted with each other. The small meeting was incredible to offer this opportunity.”
Want to see more pictures? Click here to access the Facebook gallery of pictures.
Please indicate any special dietary requirements here. We will try to cater to all dietary requirements and we will write to you if there is any problem.
Your email address will be retained in our electronic registration database and used for correspondence from the EACR.
List of Participants
If you attend, we will include your name and country in the printed programme book unless you request to be removed.
Please click below if you agree for your email address to be included in the printed List of Participants that is given to all attendees and exhibitors.
Please note: you have selected for your email address NOT to appear in the List of Participants.
You can click above to change this.
Photography and video
Please note that we will be taking photographs and video at the conference for publicity and marketing purposes. If you wish not to take part please inform the photographer.
The EACR is grateful for the continued support of its Industry Partners: